Literature DB >> 16423459

Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.

Rajnish Kumar Chaturvedi1, Shubha Shukla, Kavita Seth, Ashok Kumar Agrawal.   

Abstract

In the present study, an attempt has been made to explore the neuroprotective and neurorescue effects of nerve growth factor (NGF) on grafted cells and on host nigral dopaminergic neurons, respectively. NGF was co-transplanted with fetal ventral mesencephalic cells (VMC) in the striatum of 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease (PD). In the other groups fetal VMC and NGF were transplanted alone. Twelve weeks post-transplantation, a significant restoration was observed in D-amphetamine induced rotations (stereotypy), spontaneous locomotor activity, striatal and nigral dopamine (DA) and 3,4-dihydroxy-phenyl acetic acid (DOPAC) levels in co-transplanted rats as compared to VMC alone transplanted rats. Higher number of surviving tyrosine hydroxylase immunoreactive (TH-ir) neurons and significantly increased fiber outgrowth from graft was evident in co-transplanted rats as compared to VMC alone transplanted rats. Further, a significant increase was also observed in substantia nigra TH-ir neurons count in co-transplanted rats, exhibiting a potential neuroprotective and neurorescue effects of NGF on nigrostriatal dopaminergic neurons. The results suggest that NGF at the time of transplantation exhibits neuroprotective effect on transplanted VMC as well as neurorescue effect on remaining host nigral dopaminergic neurons, leading to better functional restoration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423459     DOI: 10.1016/j.neulet.2005.12.042

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  19 in total

Review 1.  How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson's disease?

Authors:  Jia Liu; Hong-Yun Huang
Journal:  Neurosci Bull       Date:  2007-11       Impact factor: 5.203

2.  Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease.

Authors:  Melissa K McCoy; Terina N Martinez; Kelly A Ruhn; Philip C Wrage; Edward W Keefer; Barry R Botterman; Keith E Tansey; Malú G Tansey
Journal:  Exp Neurol       Date:  2007-11-01       Impact factor: 5.330

3.  Proteasome inhibition by fellutamide B induces nerve growth factor synthesis.

Authors:  John Hines; Michael Groll; Margaret Fahnestock; Craig M Crews
Journal:  Chem Biol       Date:  2008-05

Review 4.  Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

Authors:  Tiago Martins Rodrigues; André Jerónimo-Santos; Tiago Fleming Outeiro; Ana Maria Sebastião; Maria José Diógenes
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

5.  Inhibitory Effects of Bisphenol-A on Neural Stem Cells Proliferation and Differentiation in the Rat Brain Are Dependent on Wnt/β-Catenin Pathway.

Authors:  Shashi Kant Tiwari; Swati Agarwal; Brashket Seth; Anuradha Yadav; Ratan Singh Ray; Vijay Nath Mishra; Rajnish Kumar Chaturvedi
Journal:  Mol Neurobiol       Date:  2014-11-09       Impact factor: 5.590

6.  Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson's disease.

Authors:  Ming Li; Shi-Zhong Zhang; Yan-Wu Guo; Ying-qian Cai; Zhong-jie Yan; Zhihao Zou; Xiao-Dan Jiang; Yi-Quan Ke; Xu-ying He; Zeng-liang Jin; Guo-hui Lu; Dao-qing Su
Journal:  Neurochem Res       Date:  2010-07-24       Impact factor: 3.996

7.  Functional restoration using basic fibroblast growth factor (bFGF) infusion in Kainic acid induced cognitive dysfunction in rat: neurobehavioural and neurochemical studies.

Authors:  Nishi Srivastava; Kavita Seth; Nalini Srivastava; Vinay K Khanna; Ashok Kumar Agrawal
Journal:  Neurochem Res       Date:  2007-10-23       Impact factor: 3.996

8.  Effects of pcDNA3-beta-NGF gene-modified BMSC on the rat model of Parkinson's disease.

Authors:  Ting-Hua Wang; Zhong-Tang Feng; Peng Wei; Hui Li; Zhen-Jiang Shi; Li-Yan Li
Journal:  J Mol Neurosci       Date:  2008-02-14       Impact factor: 3.444

9.  Cerebellar brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 expression in male and female rats is differentially affected by hypergravity exposure during discrete developmental periods.

Authors:  Elizabeth M Sajdel-Sulkowska; Ming Xu; Noriyuki Koibuchi
Journal:  Cerebellum       Date:  2009-07-03       Impact factor: 3.847

10.  Increased concentrations of nerve growth factor and brain-derived neurotrophic factor in the rat cerebellum after exposure to environmental enrichment.

Authors:  Francesco Angelucci; Paola De Bartolo; Francesca Gelfo; Francesca Foti; Debora Cutuli; Paola Bossù; Carlo Caltagirone; Laura Petrosini
Journal:  Cerebellum       Date:  2009-08-19       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.